This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Macrogenics, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: David Lee Farb: Innovator in HER2/neu Antibody Pharmaceutical Compositions
Introduction
David Lee Farb is a notable inventor based in Chelmsford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize HER2/neu antibodies.
Latest Patents
Farb holds a patent for "Pharmaceutical compositions of a HER2/neu antibody and use of the same." This invention focuses on pharmaceutical compositions for storage and administration that include a HER2/neu antibody known as margetuximab, along with buffering agents and stabilizers. The invention ensures that margetuximab remains stable, and it also provides containers and kits that comprise these pharmaceutical compositions. Furthermore, the invention is directed towards the use of these compositions in treating HER2/neu-positive cancers, including breast cancer, gastric cancer, and GEJ cancer. He has 1 patent to his name.
Career Highlights
David Lee Farb is associated with Macrogenics, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in antibody compositions has positioned him as a key player in the development of targeted cancer therapies.
Collaborations
Farb collaborates with talented professionals in his field, including Yan Zhou and Krishnan Sampathkumar. Their combined efforts contribute to advancing research and development in pharmaceutical compositions.
Conclusion
David Lee Farb's work in the field of HER2/neu antibody pharmaceutical compositions exemplifies innovation in cancer treatment. His contributions are vital for the ongoing development of effective therapies for patients with HER2-positive cancers.